Periprosthetic Joint Infection Clinical Trial
Official title:
The Effect of Dilute Chlorhexidine Versus Betadine on Microbial Growth in Operative Splash Basins During Total Joint Arthroplasty: A Prospective Clinical Trial
The usage of splash basins in the setting of total knee arthroplasty and total hip arthroplasty presents a risk of contamination and subsequent periprosthetic joint infection. Previous studies have investigated the efficacy of multiple antimicrobial irrigants for preventing periprosthetic joint infection, but the results are varied. Despite several noteworthy studies on the appropriate usage of different antiseptic solutions in surgical splash basins, the current literature has several limitations. First, there are no head-to-head clinical trials comparing betadine and chlorhexidine gluconate (CHG) usage with relation to periprosthetic joint infection and splash basin contamination rates. Second, the in vitro studies directly cultured splash basin antiseptic solutions rather than culturing surgical instruments. The objective of this study is to compare the microbial contamination rate of total joint arthroplasty instruments that have been placed in surgical splash basins filled with either sterile water, 3.5% betadine, or 0.05% CHG. The overall purpose of the study is to investigate the efficacy of 0.05% CHG and determine if it is an appropriate solution to use in surgical splash basins for joint replacement surgeries. A prospective clinical trial will be conducted. Patients treated at the Keck Hospital of USC or USC Verdugo Hills Hospital for primary total hip or total knee arthroplasty will be screened for inclusion in our study. All primary surgeries will be performed according to the preferences of the operating surgeon. No deviations from standard surgical care will be made based on inclusion in this study. However, prior to surgery, patients who elect to participate will be randomized to one of three groups: (1) sterile water, (2) 3.5% betadine, or (3) 0.05% CHG.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06126614 -
Infection Prophylaxis in Total Joint Replacement
|
Phase 3 | |
| Recruiting |
NCT02530229 -
Arthrocentesis Study
|
N/A | |
| Enrolling by invitation |
NCT05640336 -
Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic Suppression
|
N/A | |
| Completed |
NCT03139539 -
Intraoperative Microbial Contamination
|
N/A | |
| Recruiting |
NCT06268795 -
A Diagnostic Test Accuracy Study Comparing Biopsy to Aspiration in Shoulder and Elbow Arthroplasty Revision Surgery (BASE Study)
|
||
| Recruiting |
NCT05357287 -
Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection
|
N/A | |
| Active, not recruiting |
NCT05084378 -
Evaluation of Emerging New Treatments for Infection Prevention in Total Joint Replacement
|
Phase 3 | |
| Recruiting |
NCT02868736 -
Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection in Synovial Fluid
|
N/A | |
| Recruiting |
NCT05284318 -
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
|
||
| Not yet recruiting |
NCT06189885 -
Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
|
N/A | |
| Enrolling by invitation |
NCT05320354 -
Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
|
||
| Recruiting |
NCT05495815 -
Proper Duration of Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention
|
N/A |